Literature DB >> 35503511

Semi-syntheses and interrogation of indole-substituted Aspidosperma terpenoid alkaloids.

Jinfeng Kang1, Todd R Lewis1, Alex Gardner1, Rodrigo B Andrade1, Rongsheng E Wang1.   

Abstract

We demonstrated here a series of Aspidosperma terpenoid alkaloids can be quickly prepared using semisynthesis from naturally sourced tabersonine, featuring multiple oxygen-based substituents on the indole ring such as hydroxy and methoxy groups. This panel of complex compounds enabled the exploration of indole modifications to optimize the indole alkaloids' anticancer activity, generating lead compounds (e.g., with C15-hydroxy, C16-methoxy, and/or C17-methoxy derivatizations) that potently inhibit cancer cell line growth in the single-digit micromolar range. These results can help guide the development of Aspidosperma terpenoid alkaloid therapeutics. Furthermore, this synthetic approach features late-stage facile derivatization on complex natural product molecules, providing a versatile path to indole derivatization of this family of alkaloids with diverse chemical functionalities for future medicinal chemistry and chemical biology discoveries.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35503511      PMCID: PMC9158539          DOI: 10.1039/d2ob00610c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.890


  30 in total

1.  A Late-Stage Functionalization Approach to Derivatives of the Pyrano[3,2- a]carbazole Natural Products.

Authors:  Krissada Norseeda; Valentina Gasser; Richmond Sarpong
Journal:  J Org Chem       Date:  2019-04-17       Impact factor: 4.354

2.  Total synthesis and biological evaluation of jerantinine E.

Authors:  Reto Frei; Davide Staedler; Aruna Raja; Raimo Franke; Florenz Sasse; Sandrine Gerber-Lemaire; Jérôme Waser
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-14       Impact factor: 15.336

3.  Studies on the total synthesis of bisindole alkaloids in the vinblastine-vincristine series.

Authors:  J P Kutney
Journal:  Lloydia       Date:  1977 Jan-Feb

4.  Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle.

Authors:  S E Malawista; H Sato; K G Bensch
Journal:  Science       Date:  1968-05-17       Impact factor: 47.728

5.  Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues.

Authors:  Hayato Ishikawa; David A Colby; Shigeki Seto; Porino Va; Annie Tam; Hiroyuki Kakei; Thomas J Rayl; Inkyu Hwang; Dale L Boger
Journal:  J Am Chem Soc       Date:  2009-04-08       Impact factor: 15.419

6.  A pair of tabersonine 16-hydroxylases initiates the synthesis of vindoline in an organ-dependent manner in Catharanthus roseus.

Authors:  Sébastien Besseau; Franziska Kellner; Arnaud Lanoue; Antje M K Thamm; Vonny Salim; Bernd Schneider; Fernando Geu-Flores; René Höfer; Grégory Guirimand; Anthony Guihur; Audrey Oudin; Gaëlle Glevarec; Emilien Foureau; Nicolas Papon; Marc Clastre; Nathalie Giglioli-Guivarc'h; Benoit St-Pierre; Danièle Werck-Reichhart; Vincent Burlat; Vincenzo De Luca; Sarah E O'Connor; Vincent Courdavault
Journal:  Plant Physiol       Date:  2013-10-09       Impact factor: 8.340

7.  Doxycycline synergizes with doxorubicin to inhibit the proliferation of castration-resistant prostate cancer cells.

Authors:  Chao Zhu; Xueting Yan; Ao Yu; Yongjian Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2017-11-01       Impact factor: 3.848

Review 8.  Total synthesis of vinblastine, related natural products, and key analogues and development of inspired methodology suitable for the systematic study of their structure-function properties.

Authors:  Justin E Sears; Dale L Boger
Journal:  Acc Chem Res       Date:  2015-01-14       Impact factor: 22.384

9.  Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase.

Authors:  Belén G Sánchez; Alicia Bort; Pedro A Mateos-Gómez; Nieves Rodríguez-Henche; Inés Díaz-Laviada
Journal:  Cancer Cell Int       Date:  2019-03-08       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.